Index by author
November 01, 2018; Volume 15,Issue 4
Bai, Changsen
- You have accessPKM2 promotes reductive glutamine metabolismMiao Liu, Yuanyuan Wang, Yuxia Ruan, Changsen Bai, Li Qiu, Yanfen Cui, Guoguang Ying and Binghui LiCancer Biology & Medicine November 2018, 15 (4) 389-399; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0122
Bai, Yuchen
- You have accessPD-L1 expression and its effect on clinical outcomes of EGFR-mutant NSCLC patients treated with EGFR-TKIsYuchen Bai, Xiaoxia Chen, Likun Hou, Jun Qian, Tao Jiang, Caicun Zhou and Maciej CiebiadaCancer Biology & Medicine November 2018, 15 (4) 434-442; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0223
Bonello, Maria
- You have accessHuman epidermal growth factor receptor targeted inhibitors for the treatment of ovarian cancerMaria Bonello, Andrew Harvey Sims and Simon Peter LangdonCancer Biology & Medicine November 2018, 15 (4) 375-388; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0062
Brassesco, María Sol
- You have accessG2/M inhibitors as pharmacotherapeutic opportunities for glioblastoma: the old, the new, and the futureAngel Mauricio Castro-Gamero, Julia Alejandra Pezuk, María Sol Brassesco and Luiz Gonzaga ToneCancer Biology & Medicine November 2018, 15 (4) 354-374; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0030
Cao, Dengfeng
- You have accessMultidisciplinary team for the diagnosis and treatment of 2 cases of primary intestinal yolk sac tumorQiujuan Huang, Changxu Liu, Ruijun Tang, Jie Li, Wei Li, Lei Zhu, Yuhong Guo, Lin Zhang, Tongyuan Qu, Lingyi Yang, Lingmei Li, Yalei Wang, Baocun Sun, Bin Meng, Jie Yan, Wengui Xu, Huilai Zhang, Dengfeng Cao and Wenfeng CaoCancer Biology & Medicine November 2018, 15 (4) 461-467; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0054
Cao, Wenfeng
- You have accessMultidisciplinary team for the diagnosis and treatment of 2 cases of primary intestinal yolk sac tumorQiujuan Huang, Changxu Liu, Ruijun Tang, Jie Li, Wei Li, Lei Zhu, Yuhong Guo, Lin Zhang, Tongyuan Qu, Lingyi Yang, Lingmei Li, Yalei Wang, Baocun Sun, Bin Meng, Jie Yan, Wengui Xu, Huilai Zhang, Dengfeng Cao and Wenfeng CaoCancer Biology & Medicine November 2018, 15 (4) 461-467; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0054
Castro-gamero, Angel Mauricio
- You have accessG2/M inhibitors as pharmacotherapeutic opportunities for glioblastoma: the old, the new, and the futureAngel Mauricio Castro-Gamero, Julia Alejandra Pezuk, María Sol Brassesco and Luiz Gonzaga ToneCancer Biology & Medicine November 2018, 15 (4) 354-374; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0030
Chen, Li
- You have accessComparison of sentinel lymph node detection performances using blue dye in conjunction with indocyanine green or radioisotope in breast cancer patients: a prospective single-center randomized studyLong Yuan, Xiaowei Qi, Yi Zhang, Xinhua Yang, Fan Zhang, Linjun Fan, Li Chen, Kongyong Zhang, Ling Zhong, Yanling Li, Sijie Gan, Wenying Fu and Jun JiangCancer Biology & Medicine November 2018, 15 (4) 452-460; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0270
Chen, Lin
- You have accessA new tumor-associated antigen prognostic scoring system for spontaneous ruptured hepatocellular carcinoma after partial hepatectomyJingjing Wu, Peng Zhu, Zhanguo Zhang, Bixiang Zhang, Chang Shu, Lin Chen, Renjie Feng, Abdoul aziz Mba'nbo koumpa, Ganxun Li and Qianyun GeCancer Biology & Medicine November 2018, 15 (4) 415-424; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0095
Chen, Weiqiang
- You have accessPrognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatmentJing Wang, Yizhuo Zhao, Qiming Wang, Li Zhang, Jianhua Shi, Zhehai Wang, Ying Cheng, Jianxing He, Yuankai Shi, Hao Yu, Yang Zhao, Weiqiang Chen, Yi Luo, Xiuwen Wang, Kejun Nan, Faguang Jin, Jian Dong, Baolan Li, Zhujun Liu, Baohui Han and Kai LiCancer Biology & Medicine November 2018, 15 (4) 443-451; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0158
In this issue





